Cargando…
Conference Report: European Society for Medical Oncology Congress 2022
The European Society of Medical Oncology took place in Paris Convention Centre, Paris, France on 9th −13th September 2022 and was attended by more than 28,000 delegates, 23,000 of which were in person and 5000 online. This was the first on-site ESMO congress after the COVID-19 pandemic. This report...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989427/ https://www.ncbi.nlm.nih.gov/pubmed/36895524 http://dx.doi.org/10.1177/20363613231162474 |
_version_ | 1784901764533714944 |
---|---|
author | Dogan, Sevda |
author_facet | Dogan, Sevda |
author_sort | Dogan, Sevda |
collection | PubMed |
description | The European Society of Medical Oncology took place in Paris Convention Centre, Paris, France on 9th −13th September 2022 and was attended by more than 28,000 delegates, 23,000 of which were in person and 5000 online. This was the first on-site ESMO congress after the COVID-19 pandemic. This report focuses on a selection of talks delivered at the conference. There was a vast collection of interesting talks, nevertheless, I attended talks that focused on rare cancers. |
format | Online Article Text |
id | pubmed-9989427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-99894272023-03-08 Conference Report: European Society for Medical Oncology Congress 2022 Dogan, Sevda Rare Tumors Editorial The European Society of Medical Oncology took place in Paris Convention Centre, Paris, France on 9th −13th September 2022 and was attended by more than 28,000 delegates, 23,000 of which were in person and 5000 online. This was the first on-site ESMO congress after the COVID-19 pandemic. This report focuses on a selection of talks delivered at the conference. There was a vast collection of interesting talks, nevertheless, I attended talks that focused on rare cancers. SAGE Publications 2023-03-03 /pmc/articles/PMC9989427/ /pubmed/36895524 http://dx.doi.org/10.1177/20363613231162474 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Editorial Dogan, Sevda Conference Report: European Society for Medical Oncology Congress 2022 |
title | Conference Report: European Society for Medical Oncology Congress 2022 |
title_full | Conference Report: European Society for Medical Oncology Congress 2022 |
title_fullStr | Conference Report: European Society for Medical Oncology Congress 2022 |
title_full_unstemmed | Conference Report: European Society for Medical Oncology Congress 2022 |
title_short | Conference Report: European Society for Medical Oncology Congress 2022 |
title_sort | conference report: european society for medical oncology congress 2022 |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989427/ https://www.ncbi.nlm.nih.gov/pubmed/36895524 http://dx.doi.org/10.1177/20363613231162474 |
work_keys_str_mv | AT dogansevda conferencereporteuropeansocietyformedicaloncologycongress2022 |